Clinical Trials Browser

OTHER × Pancreatic Neoplasms × Anti-Bacterial Agents × Clear all

NCT03631173 2026-04-28

MINIMUM

Phase NA Active not recruiting

Gastrointestinal

Biliary Tract Neoplasms, Duodenal Neoplasms, Pancreatic Fistula, Pancreatic Neoplasms

NCT05462496 2024-10-15

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

Phase 2 Recruiting

Gastrointestinal

Pancreatic Neoplasms